PROLOR Biotech (PBTH) pops today, +11.3% to $5.61, after yesterday's initiation of coverage by Morgan Joseph at Buy with a target of $16. Also this week, Summer Street initiated coverage with a target of $8. The company develops therapeutic proteins and has full Phase II trial results ahead.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs